Suivre
Jean-Emmanuel Bibault, MD, PhD
Jean-Emmanuel Bibault, MD, PhD
Full professor of Radiation Oncology, Hôpital Européen Georges Pompidou, Université de Paris
Adresse e-mail validée de aphp.fr - Page d'accueil
Titre
Citée par
Citée par
Année
Big data and machine learning in radiation oncology: state of the art and future prospects
JE Bibault, P Giraud, A Burgun
Cancer letters 382 (1), 110-117, 2016
3212016
Deep learning and radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
JE Bibault, P Giraud, M Housset, C Durdux, J Taieb, A Berger, R Coriat, ...
Scientific reports 8 (1), 12611, 2018
2072018
When chatbots meet patients: one-year prospective study of conversations between patients with breast cancer and a chatbot
B Chaix, JE Bibault, A Pienkowski, G Delamon, A Guillemassé, P Nectoux, ...
JMIR cancer 5 (1), e12856, 2019
1652019
A chatbot versus physicians to provide information for patients with breast cancer: blind, randomized controlled noninferiority trial
JE Bibault, B Chaix, A Guillemassé, S Cousin, A Escande, M Perrin, ...
Journal of medical Internet research 21 (11), e15787, 2019
1322019
Deep learning: a review for the radiation oncologist
L Boldrini, JE Bibault, C Masciocchi, Y Shen, MI Bittner
Frontiers in oncology 9, 977, 2019
1322019
Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity
JE Bibault, S Dewas, C Vautravers-Dewas, A Hollebecque, H Jarraya, ...
PloS one 8 (10), e77472, 2013
1252013
Radiomics and machine learning for radiotherapy in head and neck cancers
P Giraud, P Giraud, A Gasnier, R El Ayachy, S Kreps, JP Foy, C Durdux, ...
Frontiers in oncology 9, 174, 2019
1062019
Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer
JE Bibault, B Prevost, E Dansin, X Mirabel, T Lacornerie, E Lartigau
Radiation oncology 7, 1-7, 2012
982012
Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
S Dewas, JE Bibault, X Mirabel, I Fumagalli, A Kramar, H Jarraya, ...
Radiation Oncology 7, 1-9, 2012
912012
Healthcare ex Machina: Are conversational agents ready for prime time in oncology?
JE Bibault, B Chaix, P Nectoux, A Pienkowski, A Guillemasé, B Brouard
Clinical and translational radiation oncology 16, 55-59, 2019
852019
Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations
B Chaix, G Delamon, A Guillemassé, B Brouard, JE Bibault
General psychiatry 33 (6), 2020
802020
Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results
S Dewas, JE Bibault, X Mirabel, P Nickers, B Castelain, T Lacornerie, ...
Radiation Oncology 6, 1-8, 2011
682011
Adjuvant radiation therapy in metastatic lymph nodes from melanoma
JE Bibault, S Dewas, X Mirabel, L Mortier, N Penel, L Vanseymortier, ...
Radiation Oncology 6, 1-6, 2011
672011
Radiomics: A primer for the radiation oncologist
JE Bibault, L Xing, P Giraud, R El Ayachy, N Giraud, P Decazes, A Burgun
Cancer/Radiothérapie 24 (5), 403-410, 2020
652020
Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review
JE Bibault, I Fumagalli, C Ferté, C Chargari, JC Soria, E Deutsch
Cancer and Metastasis Reviews 32, 479-492, 2013
652013
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
JE Bibault, M Figeac, N Hélevaut, C Rodriguez, S Quief, S Sebda, ...
Oncotarget 6 (26), 22812, 2015
622015
A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
I Fumagalli, JE Bibault, S Dewas, A Kramar, X Mirabel, B Prevost, ...
Radiation oncology 7, 1-8, 2012
612012
Recommended ESTRO core curriculum for radiation oncology/radiotherapy 4th edition
K Benstead, PC Lara, D Andreopoulos, JE Bibault, A Dix, YG Eller, ...
Radiotherapy and Oncology 141, 1-4, 2019
522019
IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy
C Ferté, Y Loriot, C Clémenson, F Commo, A Gombos, JE Bibault, ...
Molecular cancer therapeutics 12 (7), 1213-1222, 2013
522013
Delineation in thoracic oncology: a prospective study of the effect of training on contour variability and dosimetric consequences
S Dewas, JE Bibault, P Blanchard, C Vautravers-Dewas, Y Pointreau, ...
Radiation Oncology 6, 1-9, 2011
462011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20